SIRT6 and pancreatic neoplasm: Little is known of the other sirtuins, with the exception of SIRT 6, which has been reported to promote cytokine production and migration in pancreatic cancer cells, accordingly it was suggested that SIRT6 inhibitors may serve as a novel treatment for pancreatic cancer [26].